68Ga-DOTATATE PET/CT for neuroblastoma imaging
Part of Cancer clinical trials.
This study tests how well a new PET/CT scan using 68Ga-DOTATATE can find neuroblastoma. It’s for children and young adults who are being planned for a different scan (123I-MIBG) to compare imaging results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) has newly suspected or confirmed neuroblastoma, or neuroblastoma that has come back
- A doctor has planned a 123I-MIBG imaging scan
- Age is 1 day to 21 years old
- You can sign consent in French or English (or a parent/legal guardian can)
- No treatment right now (the study requires you not to be under treatment at the time of scanning)
- No tumor procedure between the 123I-MIBG scan and the 68Ga-DOTATATE PET/CT scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new PET scan tracer (18F-MFBG) against the standard SPECT scan (123I-MIBG) to see if it better shows neuroblastoma tumors. It's for children whose cancer has come back or hasn't responded to treatment.
This Phase 2 trial tests a targeted radioactive medicine called 177Lutetium-DOTATATE in children with high-risk neuroblastoma that has returned or did not respond to treatment. It’s designed for tumors that show strong uptake on special scans, which may help the medicine find and treat cancer cells.
This trial uses a special PET scan called 18F-mFBG to take pictures of neuroblastoma tumors. It helps doctors see where the cancer is and whether treatment is working.
This trial compares two different nuclear medicine scans to see which one best shows where neuroblastoma is in a child’s body. The results may help doctors choose the most helpful scan for planning care.
This early-phase trial uses a special PET/CT scan to help evaluate neural crest tumors, which include conditions like neuroblastoma. It may help doctors understand how well the scan shows tumor activity to guide diagnosis and treatment planning.
This trial uses special PET/CT or SPECT/CT scans that light up certain types of tumor cells (neuroblastoma and pheochromocytoma/paraganglioma). The scans help doctors see where the cancer is, how far it has spread, and whether treatment is working.
Hear when a new Neuroblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.